ITI Ultra Short Duration Annually IDCW Payout Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹5,000

ITI Ultra Short Duration Annually IDCW Payout Direct Plan

NAV
₹1,161.2650
+0.02%
(23 Feb)
AUM
140 Cr
TER
0.1%
Risk
Low to Moderate Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+7.7%
+7.6%
+7.5%
+7.5%
+7.4%
3Y
+7.4%
+7.2%
+7.3%
+7.3%
NA
5Y
+5.6%
+5.5%
+5.2%
+5.2%
NA
ALL
+5.6%
+5.8%
+5.6%
+5.6%
+5.5%
VOL
2.0%
2.7%
3.8%
3.8%
0.3%
TER
0.4%
0.4%
0.4%
0.4%
0.1%
AUM
₹5,481 Cr
₹5,481 Cr
₹5,481 Cr
₹5,481 Cr
₹140 Cr
INFO
2.76
2.15
1.46
1.46
18.13
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
ITI UST Annually IDCW Payout (DP)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Jan
Top holdings
Treps 01-Feb-2024
31.1%
Canara Bank
10.7%
ICICI Securities Limited - Commercial Paper - Commercial Paper
10.3%
7.35% Govt Stock 2024
7.7%
Axis Bank Limited
7.2%
National Bank For Agriculture And Rural Development - NCD & Bonds - NCD & Bonds
7.0%
Bharat Petroleum Corporation Ltd. - NCD & Bonds - NCD & Bonds
6.5%
Small Industries Development Bank Of India - NCD & Bonds - NCD & Bonds
5.4%
Oil And Natural Gas Corporation Limited - NCD & Bonds - NCD & Bonds
5.4%
HDFC Bank Limited - NCD & Bonds - NCD & Bonds
5.3%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
-
Lock-in period
-
Exit load
No exit load
Fund objective
The investment objective of the Scheme is to generate regular income and capital appreciation through investment in a portfolio of short term debt & money market instruments such that the Macaulay duration of the portfolio is between 3 - 6 months. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Fund manager(s)
Vikrant Mehta

FAQs